Before you sell to, join or invest in Pagari Life Science Corp.
MentionFox check on Pagari Life Science Corp.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/pagari-life-science-corp-form-d-25000001
Check Pagari Life Science Corp. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Pagari Life Science Corp.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Pagari Life Science Corp. filed a Form D with the Securities and Exchange Commission on 2025-05-29.
Pagari Life Science Corp. filed a Form D notice of an exempt securities offering with the SEC on May 29, 2025. The filing reports $56K sold. Its industry group is Pharmaceuticals. It names David Feldker (Executive Officer, Director), Stephen Peipert (Executive Officer, Director), Marni Zenkewicz (Executive Officer) (SEC Form D, May 29, 2025).
Is this your company?
Sell to companies like Pagari Life Science Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-29 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Pagari Life Science Corp.
Free to see. No signup.
More on the people and the money behind Pagari Life Science Corp., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Pagari Life Science Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Pagari Life Science Corp. raises, hires or launches. No email unless you switch it on.
Watch Pagari Life Science Corp. →Get the full cited report on Pagari Life Science Corp.
What the filing shows about Pagari Life Science Corp.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Pagari Life Science Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Pagari Life Science Corp.'s address as 333 West Bethalto Drive, Bethalta, IL 62010.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Pagari Life Science Corp. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Pagari Life Science Corp. See pricing
Pagari Life Science Corp. is a registered filer with the SEC (CIK 1993125) and has filed since 2023-10-27. 4 filings are on record, the latest on 2026-05-12.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Pagari Life Science Corp.'s Form D of 2025-05-29 names David Feldker, Stephen Peipert, Marni Zenkewicz and 1 more as its officers, directors or promoters.
Its new offerings report $678K sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
David Feldker is named as Executive Officer and Director on the Form D that Pagari Life Science Corp. filed with the SEC on 29 May 2025, one of 4 people that filing names.
Stephen Peipert is named as Executive Officer and Director on the Form D that Pagari Life Science Corp. filed with the SEC on 29 May 2025, one of 4 people that filing names.
Marni Zenkewicz is named as Executive Officer on the Form D that Pagari Life Science Corp. filed with the SEC on 29 May 2025, one of 4 people that filing names.
James Wickenhauser is named as Executive Officer on the Form D that Pagari Life Science Corp. filed with the SEC on 29 May 2025, one of 4 people that filing names.
4 people named on the filing — 4 holding an executive role.
Named as of the 2025-05-29 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Pagari Life Science Corp.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Pagari Life Science Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pagari Life Science Corp. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Pagari Life Science Corp.You get an alert in MentionFox the next time this company shows up.
If you're behind Pagari Life Science Corp.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-02 (pagarilifescience.com).
Each opens in a new tab, filled in for Pagari Life Science Corp.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/pagari-life-science-corp-form-d-25000001